Photoactivated hypericin and the use thereof

Details Photoactivated hypericin and the use thereof Photoactivated hypericin and the use thereof

1997-07-03

1999-12-14

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ketone doai

514863, 514885, 514903, 514908, A61K 3112

Patent

active

060018828

ABSTRACT:
The invention provides methods of using photoactivated hypericin compounds which, when photoactivated using visible or UV-A light, are useful for treating numerous diseases and disorders in mammals. The compounds of the invention are useful for inhibiting the proliferation and accumulation of mammalian leukocytes and for inducing apoptosis in mammalian leukocytes.

REFERENCES:
patent: 4898891 (1990-02-01), Lavie et al.
patent: 5120412 (1992-06-01), Mazur et al.
patent: 5316768 (1994-05-01), Hughes et al.
patent: 5506271 (1996-04-01), Meruelo et al.
patent: 5514714 (1996-05-01), Meruelo et al.
Agostinis et al., 1995, "Photosensitized Inhibition of Growth Factor-Regulated Protein Kinase by Hypericin", Biochem. Pharmacol. 49:1615-1622.
Anker et al., 1994, "Hypericin in adjuvant brain tumor therapy", Drugs Future 20:511-517.
Ault, 1983, Diag. Immunol. 1:2-10.
Boyum, 1964, "Separation of White Blood Cells", Nature 793-794.
Brockmann et al., 1953, "Die Synthese de Hypericins", Naturwiss. 40:411.
Brockmann et al., 1950, "Die Umwandung von Penicillopsin in Hypericin", Naturwiss. 38:47.
Calzavara-Pinton et al., 1996, "Photodynamic therapy with stemic administration of photosensitizers in dermatology", J. Photochem. Photobiol. B-Biol. 36:225-231.
Couldwell et al., 1994, "Hypericin: A Potential Antiglioma Therapy", Neurosurg. 35:705-710 [erratum appears in 1994, Neurosurgery 35:993.
Diwu et al., 1994, "Phototherapeutic Potential of Alternative Photosenitizers to Porphyrins",Pharmacol. Ther. 63:1-35.
Duran et al., 1986, "Hypericin and its Photodynamic Action", Photochem. Photobiol. 433:677-680.
Fox et al. 1993, "Evidence that TGF-.beta. Can Inhibit Human T-Lymphocyte Proliferation through Paracrine and Autocrine Mechanisms", Cell. Immunol. 150:45-58.
Goodman et al., 1985, The Pharmacological Basis of Therapeutics, Macmillan, New York--too voluminous to submit.
Hamilton et al., 1996, "Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application", J. Neurosurg. 85:329-334.
Jarvis et al., 1994, Induction of Apoptotic DNA Fragmentation and Cell Death in HL-60 Human Promyelocytic Leukemia Cells by Pharmacological Inhibitors of Protein Kinase C.sup.1, Canc. Res. 54:1707-1714.
Lavie et al., 1989, "Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin", Proc. Natl. Acad. Sci. U.S.A. 86:5963-5967.
Lavie et al., 1995, "Hypericin as an inactivator of infectiour viruses in blood components", Transfusion 35:392-400.
Levy, 1994, "Photosensitizers in Photodynamic Therapy", Sem. Oncol. 21(6 Suppl. 15):4-10.
Longnecker, 1994, "Biochemical and Genetic Studies of Epstein-Barr Virus Latent Membrane Protein 2", Leukemia 8:546-550.
Neitzel, 1986, "A ruotine method for the establishment of permanent growoing lymphoblastoid cell lines", Hum. Gen. 73:320-326.
Parrish et al, 1974, "Photochemotherapy of Psoriasis and oral methoxypsoralen and long-wave ultraviolet light", N. Engl. J. Med. 291:1207-1211.
Polack, 1996, "c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1", Proc. Natl. Acad. Sci. U.S.A. 93:10411-10416.
Ross et al., 1985, "Evaluation of an Automated Hematology System (Technicon H-1)", Arch. Pathol. Lab. Med. 110:803-808.
Sgonc, 1994, Simultnaeous determination of cell surface antigens and apoptosis:, Trends Gen. 10:41-42.
Song et al., 1979, J. Photochem. Photobiol. 29:1177-1197.
Wolff, 1997, "Should PUVA be abandoned?",New Eng. J. Med. 336:1090-1091.
Stringer et al., 1996, "The Accumulation of Protoporphyrin IX in Plaque Psoriasis After Topical Application of 5-Aminovulinic Acid Indicates a Potential for Superficial Photodyamic Therapy", J. Invest. Dermatol. 107:76-81.
Thomas et al., 1992, "Oxygen Dependence of Hypericin-Induced Phototoxicity to EMT6 Mouse Mammary Carcinoma Cells", Photochem. Photobiol. 55(6):831-837.
VIMRx Pharmaceuticals Inc., "Hypericin (VIMRxyn.RTM.), A Promising New Antiviral and Anticancer Agent", pp. 1-4 (1996).
Vandenbogaerde et al., 1996, "Antitumour Activity of Photosensitized Hypericin on A431 Cell Xenografts", Anticanc. Res. 16:1619-1626.
Zhang et al., 1996, "Malignant Glioma Sensitivity to Radiotherapy, High-dose Tamoxifen, and Hypericin: Corroborating Clinical Response in vitro: Case Report", Neurosurg. 38:587-591.
Zhang et al., 1995, "Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C", Canc. Lett. 96:31-35.

Affiliated with

Also associated with

Rating

Photoactivated hypericin and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Photoactivated hypericin and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Photoactivated hypericin and the use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-863979